Antibody therapy provides protection against severe H5N1 avian flu in monkeys

Post author:admin
Post published:January 30, 2025
Post category:uncategorized

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in Science.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Bio-Rad launches vericheck ddPCR replication competent lentivirus and replication competent AAV kits for cell and gene therapy production

Researchers uncover protective role of dopamine in regulating tau function

Study finds no link between anxiety or depression and IVF outcomes in men

Helpful Links

Subscribe To Us